The rally was broad-based, with SOL and AVAX advancing nearly 10% over the past 24 hours.Markets, news, Market Wrap, Bitcoin, Solana, Avalanche, LiquidationsRead More
You might also be interested in reading Iovance climbs after FDA rejection for Replimune’s skin cancer drug.